Latest "Utility AIMS65 score predicting mortality patients presenting with" News Stories

00:48 EDT 20th July 2018 | BioPortfolio

Here are the most relevant search results for "Utility AIMS65 score predicting mortality patients presenting with" found in our extensive news archives from over 250 global news sources.

More Information about Utility AIMS65 score predicting mortality patients presenting with on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Utility AIMS65 score predicting mortality patients presenting with for you to read. Along with our medical data and news we also list Utility AIMS65 score predicting mortality patients presenting with Clinical Trials, which are updated daily. BioPortfolio also has a large database of Utility AIMS65 score predicting mortality patients presenting with Companies for you to search.

Showing "Utility AIMS65 score predicting mortality patients presenting with" News Articles 1–25 of 20,000+

Friday 20th July 2018

Europe Wound Management Market Segmented by Product, Wound healing therapies and Geography Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $1922

Wound care is performed by nurses under the physician's orders for many of the injuries caused to the patients. There are a wide range of wounds, such as surgical, pressure or decubitus ulcer, venous stasis ulcer, arterial ulcer, diabetic ulcer, and traumatic. The Europe wound management market is expected to register a CAGR of 3.6% during 20182023 the forecast period. Increasing Incidences of Chr...

Thursday 19th July 2018

US Minimally Invasive Surgery Devices Market Segmented by Product Type, Technology, Application, and Geography Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $3000

The US minimally invasive surgery device market has been estimated at USD 4.4 billion in 2017. The market is expected to register a CAGR of 8.65% during the forecast period, 2018 to 2023. Minimally invasive surgeries are increasing now and gaining importance among the people. Minimally invasive surgeries are now preferred over the conventional invasive surgeries due to the satisfaction of the pati...

Shanghai Green Valley Reports Positive Results from Phase III Trial of Alzheimer's Drug

Shanghai Green Valley Pharma reported positive results from a China Phase III trial of its Alzheimer's treatment in patients with mild-to-moderate disease. The double-blinded 36-week trial met its primary endpoint, showing "significantly improved" scores on assessment scales, though the company did not disclose specific results. The drug, GV-971, is an oligosaccharide molecule extracted from seawe...

[Comment] Improving Plasmodium vivax malaria treatment: a little more chloroquine

The efficacy of first-line malaria treatment underpins the success of malaria control programmes. Left untreated, malaria infections will generally recur over many months. These recurrences increase malaria morbidity and enhance transmission. Crucially, suboptimal parasite clearance promotes the emergence of drug resistance. Thus, treatment should aim at total parasite elimination. Defining optima...

[Articles] Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind, randomised controlled trial

Urine-based tuberculosis screening did not reduce overall mortality in all HIV-positive inpatients, but might benefit some high-risk subgroups. Implementation could contribute towards global targets to reduce tuberculosis mortality.

[Comment] New strategies for inpatients with HIV and tuberculosis

Decreasing tuberculosis-related mortality—particularly in people living with HIV infection, who account for 22% of all tuberculosis deaths—is a pressing global health concern.1 Tuberculosis cascade-of-care analyses show that diagnosis is the weakest link.2,3 There is an urgent need for a non-sputum based, point-of-care diagnostic test for tuberculosis, particularly for groups such as those liv...

[Comment] No gains with plasma-first resuscitation in urban settings?

In 1943, during World War 2, Major General Norman Kirk, the Surgeon General of the US Army, was asked by the American Medical Association what was responsible for the higher-than-expected survival among soldiers wounded in combat. He quickly replied, “The foremost lifesaver is plasma…without that, many men would have died.” From a physiological perspective it makes sense to give blood produc...

China Respiratory Devices Market Segmented by Diagnostic and Monitoring Devices, Therapeutic Devices, and Disposables Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $1920

The China respiratory device market is estimated to record a CAGR of approximately 10% during 2018 to 2023 the forecast period. The China respiratory device market is segmented by diagnostic and monitoring device, by therapeutic device and disposables. Technological Advancement in Respiratory Devices The respiratory device market is now shifting to incorporate more ergonomic design features, to si...

Novel Combinations Advance Through RCC Pipeline

Peter J. Van Veldhuizen, MD, discusses available and emerging therapies for patients with kidney cancer.

Why insider threats to cybersecurity shouldn’t be ignored

A survey of 101 healthcare workers in IT and business/clinical positions asked respondents to rate their level of concern about insider cybersecurity threats, with 1 being not at all concerned and 10 being extremely concerned. The mean score was 8.2.

Brazil's 'Dr. Butt' plastic surgeon arrested after patient death: police

A plastic surgeon known as "Dr. Bumbum" or "Dr. Butt" on social media because of his buttock-enhancement operations was arrested on Thursday in Rio de Janeiro, four days after one of his patients died, police said.

Inogen to Announce Second Quarter 2018 Financial Results on Tuesday, August 7, 2018

Inogen, Inc. (Nasdaq:INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release second quarter 2018 financial results after market close on Tuesday, August 7, 2018. The Company will host a corresponding conference call beginning at 1:30pm PT/4:30pm ET. ...

ACADIA Pharmaceuticals Announces Appointment of Austin D. Kim as Executive Vice President, General Counsel and Secretary

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system (CNS) disorders, today announced that Austin D. Kim has joined ACADIA as Executive Vice President, General Counsel and Secretary. He will report to Steve Da...

UCSF and Dignity Health to Develop Digital Patient Experience Platform

Dignity Health and UCSF, announced a collaboration partnership to develop a digital patient experience platform that will provide information and access to patients when and where they need it as they navigate primary and preventive care, as well as more acute or specialty care. The new platform will utilize Dignity Health’s cloud-based infrastructure for its 40 ... Read More

Low/no calorie soft drinks linked to improved outcomes in advanced colon cancer patients

Drinking artificially-sweetened beverages is associated with a significantly lower risk of colon cancer recurrence and cancer death, a team of investigators led by a Yale Cancer Center scientist has found. The study was published today in the journal...

Atopic Dermatitis Places Heavy Burden on Patients

THURSDAY, July 19, 2018 -- Atopic dermatitis (AD) dramatically impacts the quality of life of patients, according to a study published online July 16 in the Annals of Allergy, Asthma & Immunology. Jonathan I. Silverberg, M.D., Ph.D., from...

Merck Reinforces Commitment to Responsible Pricing

Merck (NYSE:MRK), known as MSD outside the United States and Canada, has a long history of responsible pricing. In 2017, Merck issued its second annual Pricing Action Transparency Report, which showed that net prices across Merck’s U.S. product portfolio declined by 1.9 percent. We believe that further changes are still necessary to help reduce patient o...

Atezolizumab Regimen Extends PFS in Frontline Nonsquamous NSCLC

Adding atezolizumab to pemetrexed and cisplatin or carboplatin in the frontline setting reduced the risk of disease progression or death versus chemotherapy alone in patients with advanced nonsquamous non–small cell lung cancer, according to findings from the phase III IMpower132 study.  

Your NEJM Group Today: Patient Innovation / DOACs for VTE in Patients with Cancer / Wisc. Endocrinology Opportunity

Have a look at what we picked for you today: NEJM Catalyst: How much are clinicians opening up to patient innovation? NEJM Journal Watch...

Inventiva Reports First-half 2018 Financial Results and Provides a Corporate Update

 Inventiva Reports First-half 2018 Financial Results and Provides a Corporate Update Cash position at €75.9 million as of June 30, 2018 Successful €32.5 million private placement on April 17, 2018 (net proceeds) strengthening the company's cash position Revenues of the first half-year at €1.5 million in line with forecasts Daix (France) le 19 juillet 2018 -...

ThromboGenics Reports Day 150 Topline Data from its Phase 1/2 Clinical Study evaluating THR-317 (anti-PlGF) for the Treatment of Diabetic Macular Edema (DME)

Press release Study results confirm safety and tolerability of THR-317 for intra-ocular use, and show improvement in visual acuity for up to 90 days after last injection Leuven, Belgium, 19 July 2018 - ThromboGenics NV (Euronext Brussels: THR), a biotechnology company developing novel medicines for back of the eye diseases focused on diabetic eye conditions, reports Day 150 toplin...

Medtronic Clinical Trial to Evaluate ECG Belt for Optimizing Heart Failure Therapy

DUBLIN - July 19, 2018 - Medtronic plc (NYSE: MDT) today announced first enrollments in a new clinical trial evaluating the ECG (electrocardiography) Belt Research System (ECG Belt) as a diagnostic tool for optimizing cardiac resynchronization therapy (CRT) for patients with heart failure. The first patient enrolled in the ECG Belt for CRT Response trial was at Mercy Medical Center...

Updated Exercise Guidelines for Adults With Arthritis

New recommendations from EULAR on physical activity for patients with inflammatory or osteoarthritis mirror those for the general population. Medscape Medical News

A Spike in Liver Disease Deaths Among Young Adults Fueled by Alcohol

(NPR) – The analysis revealed that deaths from liver-related illnesses have increased dramatically, and mortality in young people rose the fastest. Although these illnesses can be caused by several things including obesity and hepatitis C infection, the rise among young … Read More

Mersana's ADC Technology Faces A Setback With Partial Clinical Trial Hold

A patient death in a Phase I dose-escalation study of XMT-1522 in patients with HER2-expressing tumors rattled investors, but CEO...   

Quick Search


News Quicklinks